Advanced Filters
noise

Immune Thrombocytopenic Purpura Clinical Trials

A listing of Immune Thrombocytopenic Purpura medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 116 clinical trials
S Sangita Sethuram, MBA

Resilience in Adolescent Development

RAD is a 10-year natural history, longitudinal, prospective assessment study of a cohort of 2,500 participants (ages 10-24 years) that will help uncover the socio-demographic, lifestyle, clinical, psychological, and neurobiological factors that contribute to resilience among children, adolescents, and young adults at-risk for mood and anxiety disorders. As this is …

10 - 24 years of age All Phase N/A
L Lai Jiang, PhD

EGR2 and NLRP3 Pathways in Obstructive Sleep Apnea-Related Cognitive and Mood Disorders

Obstructive sleep apnea-hypopnea syndrome (OSAS) is a common disorder in which repeated airway blockages during sleep lead to low oxygen levels, inflammation, and disrupted sleep. Many OSAS patients-both children and adults-experience problems with memory, attention, and mood, such as anxiety or depression. However, the exact molecular drivers of these brain …

5 years of age All Phase N/A
S Silvie Rajnochova Bloudickova, MD, PhD

Comprehensive Geriatric Assessment in Kidney Transplantation

This observational study aims to analyze the results of comprehensive geriatric assessment and to monitor the development of functional status in geriatric kidney transplant candidates and recipients.

60 years of age All Phase N/A
P Pernille Hegre Sørensen

Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy

The overall aim of the current project is to assess the acute and long term outcome of ECT (both patient and clinician rated) in a non-selected patient cohort from ordinary clinical activity, and to seek out factors predicting response and remission, side effects and relapse.

18 years of age All Phase N/A
L Lan Luo, Doctor of Medicine

A Study on the Preference of Risperidone Dosage Forms

This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.

18 years of age All Phase N/A

Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders

This study is intended to help develop new MRI imaging techniques for studying mood and anxiety disorders. Researchers believe that depression and anxiety disorders may cause structural and functional changes in the brain. This study will optimize the way MRI scans are collected to look at brain structure and examine …

18 - 65 years of age All Phase N/A
L Lise Laclautre

Validation of the French Version of the Perinatal Assessment of Paternal Affectivity (PAPA)

The transition to parenthood is a critical period for both the woman and her partner, and this can affect the mental health of the parents. Like mothers, fathers are at risk of stress, anxiety, depression and post-traumatic stress disorder during the perinatal period. Existing screening or diagnostic tools have been …

18 years of age All Phase N/A
T Théodore Vinais, Master degree

Sensory Profile and Early Clinical Signs of Calm Room Users

This descriptive study aims primarily to characterize the sensory profile of patients in a closed psychiatric hospital unit who use a calming room. The main questions it aims to answer are : Could sensory information processing disorders be the cause of distress and tension in these patients? Could users of …

18 - 65 years of age All Phase N/A

Clinical Validation of Samsung Smartwatch

Objective Wearable technology holds promising potential for mental health monitoring and detection. Samsung has developed an algorithm that they believe can detect signs of depression and anxiety in smartwatch users. They have used this algorithm to create a "Mindfulness Index," which is an easily understood visual index of mental health. …

18 - 65 years of age All Phase N/A
S Sara SP Poletti, phd

Inflammatory Control of Antidepressant Efficacy: a Pharmaco-epigenetic Approach

Major depressive disorder (MDD) is a chronic, recurring and potentially life-threatening illness that affects up to 10% of the population across the globe.It posits that the increase in serotonin levels induced by Selective Serotonin Reuptake Inhibitors (SSRIs) does not affect mood per se, but enhances brain plasticity and thus amplifies …

18 - 65 years of age All Phase N/A

Simplify language using AI